French (CAC) Specialty Chemicals Industry Analysis

Industry Valuation and Performance

Has the French Specialty Chemicals Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Sun, 10 May 2026	€6.6b	€10.1b	€118.3m	18.2x	56x	0.7x
Tue, 07 Apr 2026	€6.2b	€10.3b	€136.3m	15.6x	45.3x	0.6x
Thu, 05 Mar 2026	€6.1b	€10.3b	€129.5m	63.3x	47.1x	0.6x
Sat, 31 Jan 2026	€5.7b	€10.5b	€217.5m	23.6x	26.2x	0.5x
Mon, 29 Dec 2025	€5.8b	€10.5b	€217.5m	23.9x	26.4x	0.5x
Wed, 26 Nov 2025	€5.9b	€10.5b	€217.5m	24.4x	26.9x	0.6x
Fri, 24 Oct 2025	€5.8b	€10.7b	€282.1m	18.9x	20.7x	0.5x
Sun, 21 Sep 2025	€6.0b	€10.7b	€279.7m	21x	21.5x	0.6x
Tue, 19 Aug 2025	€6.4b	€10.7b	€255.6m	20.3x	25.2x	0.6x
Thu, 17 Jul 2025	€6.4b	€10.8b	€372.6m	17.5x	17.2x	0.6x
Sat, 14 Jun 2025	€6.4b	€10.8b	€372.6m	18.3x	17.1x	0.6x
Mon, 12 May 2025	€6.7b	€10.8b	€365.6m	18.2x	18.5x	0.6x
Wed, 09 Apr 2025	€6.5b	€10.7b	€395.6m	15.3x	16.3x	0.6x
Fri, 07 Mar 2025	€8.3b	€10.7b	€396.2m	19.9x	20.9x	0.8x
Sun, 02 Feb 2025	€7.8b	€10.6b	€404.2m	20.6x	19.2x	0.7x
Tue, 31 Dec 2024	€7.4b	€10.7b	€402.8m	20.7x	18.5x	0.7x
Thu, 28 Nov 2024	€7.7b	€10.9b	€376.1m	21.1x	20.4x	0.7x
Sat, 26 Oct 2024	€8.3b	€10.9b	€393.3m	20.2x	21x	0.8x
Mon, 23 Sep 2024	€8.2b	€11.0b	€334.5m	26.8x	24.4x	0.7x
Wed, 21 Aug 2024	€8.0b	€11.0b	€334.8m	23.6x	23.8x	0.7x
Fri, 19 Jul 2024	€8.4b	€10.9b	€341.8m	23.4x	24.5x	0.8x
Sun, 16 Jun 2024	€8.2b	€10.9b	€345.2m	22.7x	23.7x	0.8x
Tue, 14 May 2024	€9.6b	€10.9b	€330.9m	25.1x	28.9x	0.9x
Thu, 11 Apr 2024	€9.3b	€11.1b	€392.4m	23.7x	23.6x	0.8x
Sat, 09 Mar 2024	€8.8b	€11.1b	€413.2m	17.2x	21.3x	0.8x
Mon, 05 Feb 2024	€9.4b	€11.4b	€404.2m	18.8x	23.3x	0.8x
Wed, 03 Jan 2024	€9.7b	€11.4b	€404.2m	19.4x	23.9x	0.8x
Fri, 01 Dec 2023	€8.8b	€11.4b	€404.2m	17.7x	21.8x	0.8x
Sun, 29 Oct 2023	€8.2b	€12.0b	€515.4m	12.6x	15.9x	0.7x
Tue, 26 Sep 2023	€8.8b	€12.1b	€517.9m	12.2x	17.1x	0.7x
Thu, 24 Aug 2023	€9.2b	€12.1b	€531.4m	14x	17.3x	0.8x
Sat, 22 Jul 2023	€9.0b	€12.8b	€780.4m	10.2x	11.6x	0.7x
Mon, 19 Jun 2023	€8.5b	€12.8b	€780.4m	10.7x	10.9x	0.7x
Wed, 17 May 2023	€8.6b	€12.8b	€783.3m	17.2x	10.9x	0.7x

Current Industry PE

Investors are optimistic on the French Specialty Chemicals industry, and appear confident in long term growth rates.

The industry is trading at a PE ratio of 47.9x which is higher than its 3-year average PE of 22.6x.

The industry is trading close to its 3-year average PS ratio of 0.69x.

Past Earnings Growth

The earnings for companies in the Specialty Chemicals industry have declined 44% per year over the last three years,
Revenues have also declined 6.9% per year.
This means overall sales from these companies are declining and profits are subsequently falling as well.

Industry Comparison

How does French Specialty Chemicals compare with similar industries?


FR Market	0.50%
Materials	-3.56%
Chemicals	-3.98%
Specialty Chemicals	0.93%
Commodity Chemicals	3.69%
Diversified Chemicals	3.15%
Industrial Gases	-4.35%
Fertilizers and Agricultural Chemicals	-6.25%

Industry PEThere are no additional sub-industries under this industry.

Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company	Last Price	7D	1Y	Valuation
AKE Arkema	€63.05	1.7% +€81.3m	-4.8%	PE280.6x
SEFER SergeFerrari Group	€7.10	9.2% +€6.9m	31.5%	PE15.1x
ALMIB Amoéba	€0.93	7.1% +€4.3m	-25.7%	PS92.3x
ALBKK Baikowski	€21.00	4.0% +€2.9m	9.4%	PE20.5x
ALVIN Vinpai SAS	€3.56	0.6% +€68.7k	3.5%	PS1.3x

Amoéba and Koppert Highlight the Potential of Axpera Technology in Brazil for Strategic Crops

Amoéba, industrial greentech specialised in the development of natural microbiological solutions based on the patented use of amoebae, announces that it has conducted, in partnership with Koppert, an extensive programme of field trials in Brazil to assess the potential of its AXPERA biofungicide technology on several key crops, such as soya and orange trees, of which Brazil is the world’s leading producer. The visit, which took place at the end of March, demonstrated the promising results of the trials and confirmed the Brazilian market’s interest in Amoéba. With regard to soya, the trial programme conducted with several contractors in various production regions has confirmed the promising performance of AXPERA, under conditions of moderate to high pressure from Asian rust. These results are all the more remarkable given that AXPERA was tested under real-world farming conditions, as a complement to a standard fungicide programme and against a backdrop of high expectations among technicians for a multi-site biofungicide in the face of the growing risk of soybean rust resistance to chemical fungicides. As for orange trees, the initial results observed against bacterial canker appear encouraging and could, in the long term, help reduce the use of copper, given the known risks of bioaccumulation in the soil. These trials conducted in Brazil, which form part of the strategic agreement signed with Koppert in June 2025, thus confirm the full potential of AXPERA technology on crops such as soya and citrus, complementing the European and American markets where the two companies focus on vines and vegetable crops. On the strength of these initial results, Amoéba is considering the potential commercialisation of its technology in Brazil in 2028, once the following steps have been completed: Obtaining approval from the Brazilian authorities, a process falling under the remit of three ministries. The Ministry of Health has already confirmed that the AXPERA product poses no risk. The Ministries of the Environment and Agriculture are currently reviewing the product for its first targeted use against soya rust, with approval currently expected in 2027. Applications to extend the authorisation to new uses will then be submitted for strategic crops and diseases defined jointly with Koppert; Final confirmation of the marketing positioning following a new trial campaign to be carried out in 2027, in other regions representative of soya and orange cultivation.

French (CAC) Specialty Chemicals Industry Analysis

Industry Valuation and Performance

Industry Comparison

Top Stock Gainers and Losers

Latest News

New minor risk - Financial data availability

Arkema EPS Exceeds Expectations as Margins Improve and Specialty Materials Drive Stability

Fermentalg SA, Annual General Meeting, Jun 11, 2026

Dividend of €0.30 announced

Dividend increased to €12.00

Serge Ferrari Group Discontinues Pet Spinning Operations At Tersuisse Site and Reduces 62 Jobs

Amoéba and Koppert Highlight the Potential of Axpera Technology in Brazil for Strategic Crops

New minor risk - Share price stability